Anebulo Pharmaceuticals (ANEB) Other Non-Current Assets (2021 - 2025)
Anebulo Pharmaceuticals' Other Non-Current Assets was $148,231 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 66.7% from $445,731 a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Other Non-Current Assets (2021 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Other Non-Current Assets at Anebulo Pharmaceuticals came in at $200,000, down 66.7% from FY2024.
- In earlier fiscal years, Other Non-Current Assets was $600,000 in FY2024.
- The fiscal Q2 2026 figure marks the lowest quarterly Other Non-Current Assets in data going back to fiscal Q3 2021.
- Compared with a year earlier, Other Non-Current Assets has declined for five straight quarters, with an average decline of 59.6% over the last five quarters.
- Per Business Quant data, ANEB's Other Non-Current Assets in the three fiscal quarters before Q2 2026 was $200,000 (Q1 2026), $200,000 (Q4 2025) and $200,549 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Anebulo Pharmaceuticals | 11.50 Mn | -32.80 Mn | - | 148,231.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 148,231.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,549.00 |
| Dec 31, 2024 | 445,731.00 |
| Sep 30, 2024 | 505,427.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 624,820.00 |
| Dec 31, 2023 | 700,000.00 |
| Mar 31, 2021 | 392,730.00 |
API Access
Anebulo Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();